Overview
Hugo Arroyo practices practicing medicine in Argentina.
His clinical expertise encompasses Myoclonic Epilepsy, Transient Tic Disorder, and Congenital Heart Disease (CHD).
He is actively involved in clinical research, co-authoring 15 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hugo A. Arroyo
Is Hugo A. Arroyo a top-rated expert for Myoclonic Epilepsy?
MediFind is an objective health platform that identifies experts based on real-world data. Hugo A. Arroyo is classified as an Experienced expert for Myoclonic Epilepsy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hugo A. Arroyo participate in research or clinical trials?
Yes. Hugo A. Arroyo has published 15 articles and abstracts on conditions like Myoclonic Epilepsy. You can view a list of Hugo A. Arroyo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Congenital Heart Disease (CHD)Mr. Arroyo isExperienced. Learn about Congenital Heart Disease (CHD).
- Myoclonic EpilepsyMr. Arroyo isExperienced. Learn about Myoclonic Epilepsy.
- Transient Tic DisorderMr. Arroyo isExperienced. Learn about Transient Tic Disorder.